The Fibroblast Growth Factor Receptor Signaling Pathway as a Mediator of Intrinsic Resistance to EGFR-specific Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

समान संसाधन

• Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations
  द्वारा: Wang, Jun, और अन्य
  प्रकाशित: (2016)
• Rapidly Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in NSCLC Cell Lines through De-Repression of FGFR2 and FGFR3 Expression
  द्वारा: Ware, Kathryn E., और अन्य
  प्रकाशित: (2010)
• Intrinsic Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance
  द्वारा: Santoni-Rugiu, Eric, और अन्य
  प्रकाशित: (2019)
• Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
  द्वारा: Soomin Kim, और अन्य
  प्रकाशित: (2025-02-01)
• Microwave ablation with continued EGFR tyrosine kinase inhibitor therapy prolongs disease control in non‐small‐cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors
  द्वारा: Li, Xin, और अन्य
  प्रकाशित: (2018)